Drug Profile
LY 03002
Alternative Names: LY03002Latest Information Update: 15 Oct 2018
Price :
$50
*
At a glance
- Originator Luye Pharma Group
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Neurological disorders
Most Recent Events
- 15 Oct 2018 Development discontinued for Neurological disorders in China